pHAGE-CMV-Luc2-IRES-ZsGreen-W Citations (18)
Originally described in: COVID-19-neutralizing antibodies predict disease severity and survival.Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB Cell. 2021 Jan 21;184(2):476-488.e11. doi: 10.1016/j.cell.2020.12.015. Epub 2020 Dec 15. PubMed Journal
Articles Citing pHAGE-CMV-Luc2-IRES-ZsGreen-W
| Articles |
|---|
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
Garcia-Beltran WF, Lam EC, St Denis K, Nitido AD, Garcia ZH, Hauser BM, Feldman J, Pavlovic MN, Gregory DJ, Poznansky MC, Sigal A, Schmidt AG, Iafrate AJ, Naranbhai V, Balazs AB.
Cell. 2021 Mar 12. pii: S0092-8674(21)00298-1. doi: 10.1016/j.cell.2021.03.013.
PubMed
Associated Plasmids |
| Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans. Vanshylla K, Di Cristanziano V, Kleipass F, Dewald F, Schommers P, Gieselmann L, Gruell H, Schlotz M, Ercanoglu MS, Stumpf R, Mayer P, Zehner M, Heger E, Johannis W, Horn C, Suarez I, Jung N, Salomon S, Eberhardt KA, Gathof B, Fatkenheuer G, Pfeifer N, Eggeling R, Augustin M, Lehmann C, Klein F. Cell Host Microbe. 2021 Jun 9;29(6):917-929.e4. doi: 10.1016/j.chom.2021.04.015. Epub 2021 May 3. PubMed |
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.
Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, Berrios C, Ofoman O, Chang CC, Hauser BM, Feldman J, Roederer AL, Gregory DJ, Poznansky MC, Schmidt AG, Iafrate AJ, Naranbhai V, Balazs AB.
Cell. 2022 Jan 6. pii: S0092-8674(21)01496-3. doi: 10.1016/j.cell.2021.12.033.
PubMed
Associated Plasmids |
| SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns. Gruell H, Vanshylla K, Korenkov M, Tober-Lau P, Zehner M, Munn F, Janicki H, Augustin M, Schommers P, Sander LE, Kurth F, Kreer C, Klein F. Cell Host Microbe. 2022 Sep 14;30(9):1231-1241.e6. doi: 10.1016/j.chom.2022.07.002. Epub 2022 Jul 7. PubMed |
| Incorporation of noncanonical base Z yields modified mRNA with minimal immunogenicity and improved translational capacity in mammalian cells. Zhang M, Singh N, Ehmann ME, Zheng L, Zhao H. iScience. 2023 Aug 26;26(10):107739. doi: 10.1016/j.isci.2023.107739. eCollection 2023 Oct 20. PubMed |
| Viral and immunologic evaluation of smokers with severe COVID-19. Vecchio J, Regan J, Jiang Y, Li R, Romain H, Yousuf F, Adel T, Hall K, DaCosta JM, Yu X, Li JZ, Fofana IB. Sci Rep. 2023 Oct 19;13(1):17898. doi: 10.1038/s41598-023-45195-z. PubMed |
| Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants. Korenkov M, Zehner M, Cohen-Dvashi H, Borenstein-Katz A, Kottege L, Janicki H, Vanshylla K, Weber T, Gruell H, Koch M, Diskin R, Kreer C, Klein F. Immunity. 2023 Dec 12;56(12):2803-2815.e6. doi: 10.1016/j.immuni.2023.11.004. Epub 2023 Nov 29. PubMed |
| Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand. Chawansuntati K, Sakkhachornphop S, Hongjaisee S, Freeouf S, Sripan P, Nusartsang N, Chaiwarith R, Sudjaritruk T, Supparatpinyo K, Wipasa J. Vaccine X. 2024 Mar 16;18:100475. doi: 10.1016/j.jvacx.2024.100475. eCollection 2024 Jun. PubMed |
| Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung. Wu TT, Travaglini KJ, Rustagi A, Xu D, Zhang Y, Andronov L, Jang S, Gillich A, Dehghannasiri R, Martinez-Colon GJ, Beck A, Liu DD, Wilk AJ, Morri M, Trope WL, Bierman R, Weissman IL, Shrager JB, Quake SR, Kuo CS, Salzman J, Moerner WE, Kim PS, Blish CA, Krasnow MA. J Exp Med. 2024 Jun 3;221(6):e20232192. doi: 10.1084/jem.20232192. Epub 2024 Apr 10. PubMed |
| APOBEC3-related mutations in the spike protein-encoding region facilitate SARS-CoV-2 evolution. Shen J, Xu X, Fan J, Chen H, Zhao Y, Huang W, Liu W, Zhang Z, Cui Q, Li Q, Niu Z, Jiang D, Cao G. Heliyon. 2024 May 29;10(11):e32139. doi: 10.1016/j.heliyon.2024.e32139. eCollection 2024 Jun 15. PubMed |
| Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity. Roederer AL, Cao Y, St Denis K, Sheehan ML, Li CJ, Lam EC, Gregory DJ, Poznansky MC, Iafrate AJ, Canaday DH, Gravenstein S, Garcia-Beltran WF, Balazs AB. Cell Rep Med. 2024 Dec 17;5(12):101850. doi: 10.1016/j.xcrm.2024.101850. Epub 2024 Dec 9. PubMed |
| Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patients. Patel SV, Leeman BM, Botros PJ, Folta J, Shahid D, Rocque AI, Joyal AS, Vecchio JA, Passell E, Tien D, Reynolds Z, Su K, Vyas TD, Vyas JM, Abar E, Barry M, Alexandrescu A, Wallace Z, DaCosta JM, Choudhary MC, Tamura T, Edelstein G, Li Y, Deo R, Sparks JA, Boucau J, Glover O, Barczak A, Lemieux J, Siedner MJ, Li JZ, Fofana IB. Res Sq [Preprint]. 2024 Dec 5:rs.3.rs-5487774. doi: 10.21203/rs.3.rs-5487774/v1. PubMed |
| Dyr726, a brain-penetrant inhibitor of PI3Kalpha, Type III receptor tyrosine kinases, and WNT signaling. Tandon V, Fistrovich A, Nogales J, Ferro F, Rokey SN, Cabel C, Miller AD, Yagel M, Duncan C, Atmasidha A, Sharma I, Wilms G, Williams K, Elliott R, Chavez T, Shaw Y, McMahon A, Ginn S, Basantes LE, Bedard N, Gokhale V, Ellis N, Prescott AR, Smith SJ, Rahman R, Becker W, Read KD, Chalmers AJ, Carragher N, Masson GR, Montfort W, Thorne C, Hulme C, Banerjee S. bioRxiv [Preprint]. 2025 Mar 29:2025.03.26.645490. doi: 10.1101/2025.03.26.645490. PubMed |
| Deep mutational scanning of rabies glycoprotein defines mutational constraint and antibody-escape mutations. Aditham AK, Radford CE, Carr CR, Jasti N, King NP, Bloom JD. Cell Host Microbe. 2025 Jun 11;33(6):988-1003.e10. doi: 10.1016/j.chom.2025.04.018. Epub 2025 May 20. PubMed |
| Single-molecule imaging prefusion intermediate conformations of MERS-CoV spike trimers in membrane during entry. Dey S, Pahari P, Shukla M, Andrabi R, Das DK. Cell Rep. 2025 Jul 22;44(7):115916. doi: 10.1016/j.celrep.2025.115916. Epub 2025 Jun 25. PubMed |
RSV F evolution escapes some monoclonal antibodies but does not strongly erode neutralization by human polyclonal sera.
Simonich CAL, McMahon TE, Ju X, Yu TC, Brunette N, Stevens-Ayers T, Boeckh MJ, King NP, Greninger AL, Bloom JD.
J Virol. 2025 Jul 3:e0053125. doi: 10.1128/jvi.00531-25.
PubMed
Associated Plasmids |
| The impact of clade B lineage 5 MERS coronaviruses spike mutations from 2015 to 2023 on virus entry and replication competence. So RTY, Lau KKM, Zhou Z, Poon LLM, Peiris M. bioRxiv [Preprint]. 2025 Jul 1:2025.06.30.662263. doi: 10.1101/2025.06.30.662263. PubMed |
| Cross-Neutralization of Distant Coronaviruses Strongly Correlates with Spike S2-Specific Antibodies from Immunocompetent and Immunocompromised Vaccinated SARS-CoV-2-Infected Patients. Patel SV, Leeman BM, Botros PJ, Folta J, Shahid D, Rocque AI, Joyal AS, Vecchio JA, Passell E, Tien D, Reynolds Z, Su K, Vyas TD, Vyas JM, Abar E, Barry M, Alexandrescu A, Wallace Z, DaCosta JM, Choudhary MC, Tamura TJ, Edelstein GE, Li Y, Deo R, Sparks JA, Boucau J, Glover OT, Barczak AK, Lemieux J, Siedner MJ, Li JZ, Fofana IB. Vaccines (Basel). 2025 Sep 4;13(9):949. doi: 10.3390/vaccines13090949. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.